The Impact of Biosimilars and Biobetters on Biopharmaceutical Manufacturing
Brian Baker, FDA
Criag Dobbs, Waters Corporation
(l-r) Ralf Kuriyel, Pall Corp. and Lynne Bartowski Fricke, Tarpon Biosystems
(l-r) Bill Hancock, Northeastern Univ., Rohin Mhatre, Biogen Idec and Jim Leung, MIT
Ajaz Hussain, Wockhardt Ltd
Rohin Mhatre, Biogen Idec
(l-r) Rohin Mhatre, Biogen Idec and Ellen McCormick, Pfizer
Steven Berkowitz, Biogen Idec